GPR39 and Cognitive impairment: In the current study, we used GPR39 mutant mice, with homozygous (KO) and heterozygous (Het) deletion of GPR39, to test the hypothesis that it plays a protective role against cognitive impairment in the HFD mouse model of metabolic syndrome.